Manufacturer record
Bajaj Healthcare Ltd. R.S. No. 1818: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Bajaj Healthcare Ltd. R.S. No. 1818 (Gujarat) were declared Not of Standard Quality between April 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TLB08B26C, Telmisartan Tablets IP 40 mg (exp Jan 2028). SDTL, Uttarakhand (state lab) found it not of standard quality: DESCRIPTION ? TABLETS HAVING BLACK SPOTS. Listed in the September 2026 alert.
Records by type
4 records linked to Bajaj Healthcare Ltd. R.S. No. 1818 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 40 mg | Batch TLB08B26CMfg Feb 2026 · Exp Jan 2028 | DESCRIPTION ? TABLETS HAVING BLACK SPOTS.Description | SDTL, UttarakhandState lab | Sep 2026 |
| Aspirin Gastro-Resistant Tablets IP 150 mg | Batch ASB02B25Mfg Feb 2025 · Exp Jan 2027 | Rough Surface on Tablets DescriptionDescription | FDTL,UttarakhandState lab | Feb 2026 |
| Oxcarbazepine Tablets IP 150 mg (OXCARBAJAJ 150) | Batch OXA01A25Mfg Jan 2025 · Exp Dec 2026 | The Sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description Only.Description | CDTL, HyderabadCDSCO lab | Oct 2025 |
| Oxcarbazepine Tablets IP 300 mg (OXCARBAJAJ 300) | Batch OXB02I24Mfg Sep 2024 · Exp Aug 2026 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.